Assignee
GENERON SHANGHAI CORP LTD
CN·6 granted patents·2 pending applications·25 citations·filing 2012–2017
Top patents by PatentIndex Score
8 records- 0187US10870701B2Multispecific fab fusion proteins and use thereofGENERON SHANGHAI CORP LTD·Filed 2017·Granted Dec 22, 2020·5 cites·20 claims
- 0287US10786551B2Use of interleukin-22 in the treatment of fatty liver diseaseGENERON SHANGHAI CORP LTD·Filed 2017·Granted Sep 29, 2020·3 cites·12 claims
- 0381US9629898B2Use of interleukin-22 in treating viral hepatitisGENERON (SHANGHAI) CORP LTD·Filed 2014·Granted Apr 25, 2017·5 cites·22 claims
- 0481US9352024B2Uses of interleukin-22(IL-22) in treating and preventing nerve damage diseases or neurodegenerative diseasesGENERON SHANGHAI CORP LTD·Filed 2012·Granted May 31, 2016·6 cites·18 claims
- 0579US10543169B2Use of IL-22 dimer in manufacture of a medicament for intravenous administrationGENERON SHANGHAI CORP LTD·Filed 2014·Granted Jan 28, 2020·4 cites·16 claims
- 0674US9273108B2Recombinant human G-CSF dimer and use thereof for the treatment of neurological diseasesGENERON SHANGHAI CORP LTD·Filed 2013·Granted Mar 1, 2016·2 cites·19 claims
- 0762US2015147290A1Use of g-csf dimer in the treatment of neutropeniaGENERON SHANGHAI CORP LTD·Filed 2014·Application pending·0 cites
- 0842US2016271221A1Use of il-22 dimers in manufacture of medicaments for treating pancreatitisGENERON (SHANGHAI) CORP LTD·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENERON SHANGHAI CORP LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →